407
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus

, , , , , , , , & show all
Pages 307-313 | Accepted 24 Nov 2013, Published online: 06 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mayumi Kawabata, Naoya Inoue, Mikio Watanabe, Ayaka Kobayashi, Yoh Hidaka, Akira Miyauchi & Yoshinori Iwatani. (2021) PD-1 gene polymorphisms and thyroid expression of PD-1 ligands differ between Graves’ and Hashimoto’s diseases. Autoimmunity 54:7, pages 450-459.
Read now
Yingying Wang, Nannan Pang, Xinyou Wang, Ying Liu, Xiujuan Wang, Lei Wang, Mingling Sun, Halida Yasen, Fang Zhao, Wenxia Fan, Xinhong Guo & Jianbing Ding. (2018) Percentages of PD-1+CD4+T cells and PD-L1+DCs are increased and sPD-1 level is elevated in patients with immune thrombocytopenia. Human Vaccines & Immunotherapeutics 14:4, pages 832-838.
Read now
Saber Imani, Jafar Salimian, Mahmood Bozorgmehr, Ensieh Vahedi, Ali Ghazvini, Mostafa Ghanei & Yunes Panahi. (2016) Assessment of Treg/Th17 axis role in immunopathogenesis of chronic injuries of mustard lung disease. Journal of Receptors and Signal Transduction 36:5, pages 531-541.
Read now
Saber Imani, Jafar Salimian, Junjiang Fu, Mostafa Ghanei & Yunes Panahi. (2016) Th17/Treg-related cytokine imbalance in sulfur mustard exposed and stable chronic obstructive pulmonary (COPD) patients: correlation with disease activity. Immunopharmacology and Immunotoxicology 38:4, pages 270-280.
Read now

Articles from other publishers (22)

Tianxiao Zhang, Shuyun Dong, Yujia Zhai, Lauren Naatz, Zemin Zhou & Mingnan Chen. (2023) Diphtheria toxin‐derived, anti‐PD‐1 immunotoxin, a potent and practical tool to selectively deplete PD‐1 + cells . Protein Science 32:9.
Crossref
Fady Mohamed El-Gendy, Amira M.F. Shehata, Esam Awad Abd El-Kawy & Mahmoud Ahmed El-Hawy. (2023) Changes and correlations of T-cell coinhibitory molecule programmed death-1 and interferon-γ in pediatric immune thrombocytopenia. Clinical and Experimental Pediatrics 66:3, pages 127-133.
Crossref
Georgios Lioulios, Zoi Mitsoglou, Asimina Fylaktou, Aliki Xochelli, Michalis Christodoulou, Stamatia Stai, Eleni Moysidou, Afroditi Konstantouli, Vasiliki Nikolaidou, Aikaterini Papagianni & Maria Stangou. (2022) Exhausted but Not Senescent T Lymphocytes Predominate in Lupus Nephritis Patients. International Journal of Molecular Sciences 23:22, pages 13928.
Crossref
Pooriya Fazeli, Atefe Ghamar Talepoor, Zahra Faghih, Nasser Gholijani, Mohammad Reza Ataollahi, Mohammad Ali‐Hassanzadeh, Hossein Moravej & Kurosh Kalantar. (2022) The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes. Immunity, Inflammation and Disease 10:10.
Crossref
Ryohei Annen, Satoshi Kato, Satoru Demura, Shinji Miwa, Akira Yokka, Kazuya Shinmura, Noriaki Yokogawa, Noritaka Yonezawa, Motoya Kobayashi, Yuki Kurokawa, Toshifumi Gabata & Hiroyuki Tsuchiya. (2022) Tumor-Specific Immunoenhancing Effects after Local Cryoablation for Metastatic Bone Tumor in a Mouse Model. International Journal of Molecular Sciences 23:16, pages 9445.
Crossref
Jan-Mou Lee, Ming-Huang Chen, Kai-Yuan Chou, Yee Chao, Ming-Han Chen & Chang-Youh Tsai. (2022) Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response. Lupus Science & Medicine 9:1, pages e000693.
Crossref
Qing Luo, Yunyuan Kong, Biqi Fu, Xue Li, Qingshui Huang, Zikun Huang & Junming Li. (2021) Increased TIM-3+PD-1+ NK cells are associated with the disease activity and severity of systemic lupus erythematosus. Clinical and Experimental Medicine 22:1, pages 47-56.
Crossref
Florian Kälble, Lisa Wu, Hanns-Martin Lorenz, Martin Zeier, Matthias Schaier & Andrea Steinborn. (2021) Impaired Differentiation of Highly Proliferative ICOS+-Tregs Is Involved in the Transition from Low to High Disease Activity in Systemic Lupus Erythematosus (SLE) Patients. International Journal of Molecular Sciences 22:17, pages 9501.
Crossref
Ming Wang, Xudong Ma, Kang Zhou, Huijuan Mao, Jiachun Liu, Xuqiong Xiong, Xiaoyin Zhao, Suresh Narva, Yoshimasa Tanaka, Yanling Wu, Chuanxin Guo, Hiroshi Sugiyama & Wen Zhang. (2021) Discovery of Pyrrole-imidazole Polyamides as PD-L1 Expression Inhibitors and Their Anticancer Activity via Immune and Nonimmune Pathways. Journal of Medicinal Chemistry 64:9, pages 6021-6036.
Crossref
Panpan Han, Tianshu Yu, Yu Hou, Yajing Zhao, Yang Liu, Yunqi Sun, Haoyi Wang, Pengcheng Xu, Guosheng Li, Tao Sun, Xiang Hu, Xinguang Liu, Lizhen Li, Jun Peng, Hai Zhou & Ming Hou. (2021) Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia. Frontiers in Immunology 12.
Crossref
Sebastian Dolff & Benjamin Wilde. (2021) Renale Manifestationen bei systemischen AutoimmunerkrankungenRenal involvement in systemic autoimmune diseases. Der Nephrologe 16:2, pages 81-90.
Crossref
Shuo Zhang, Li Wang, Mengtao Li, Fengchun Zhang & Xiaofeng Zeng. (2021) The PD-1/PD-L pathway in rheumatic diseases. Journal of the Formosan Medical Association 120:1, pages 48-59.
Crossref
Sebastian Dolff, Claudia Scharpenberg, Christof Specker, Andreas Kribben, Oliver Witzke & Benjamin Wilde. (2019) IL-22 production of effector CD4+ T-cells is altered in SLE patients. European Journal of Medical Research 24:1.
Crossref
Christoph Oster, Benjamin Wilde, Christof Specker, Ming Sun, Andreas Kribben, Oliver Witzke & Sebastian Dolff. (2019) BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease. International Journal of Molecular Sciences 20:18, pages 4505.
Crossref
Li Cai, Chenxing Zhang, Jing Wu, Wei Zhou & Tongxin Chen. (2019) Decreased PD-1 expression on circulating CD4+T cell and PD-L1 expression on myeloid dendritic cell correlate with clinical manifestations in systemic juvenile idiopathic arthritis. Joint Bone Spine 86:1, pages 61-68.
Crossref
Matthias Schaier, Claudius Gottschalk, Lorenz Uhlmann, Claudius Speer, Florian Kälble, Volker Eckstein, Carsten Müller-Tidow, Stefan Meuer, Karsten Mahnke, Hanns-Martin Lorenz, Martin Zeier & Andrea Steinborn. (2018) Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients. Arthritis Research & Therapy 20:1.
Crossref
Sung Soo Ahn, Eun Seong Park, Joo Sung Shim, Sang-Jun Ha, Beom Seok Kim, Seung Min Jung, Sang-Won Lee, Yong-Beom Park & Jason Jungsik Song. (2017) Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus. Arthritis Research & Therapy 19:1.
Crossref
Lie Mao, Hongyan Hou, Shiji Wu, Yu Zhou, Juan Wang, Jing Yu, Xiaohui Wu, Yanfang Lu, Liyan Mao, Munyemana Jean Bosco, Feng Wang & Ziyong Sun. (2017) TIGIT signalling pathway negatively regulates CD4 + T-cell responses in systemic lupus erythematosus . Immunology 151:3, pages 280-290.
Crossref
Bas C. Mourik, Erik Lubberts, Jurriaan E. M. de Steenwinkel, Tom H. M. Ottenhoff & Pieter J. M. Leenen. (2017) Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. Frontiers in Immunology 8.
Crossref
Kohei Hosokawa, Pawel Muranski, Xingmin Feng, Danielle M. Townsley, Baoying Liu, Jared Knickelbein, Keyvan Keyvanfar, Bogdan Dumitriu, Sawa Ito, Sachiko Kajigaya, James G. TaylorVIVI, Mariana J. Kaplan, Robert B. Nussenblatt, A. John Barrett, John O’Shea & Neal S. Young. (2016) Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia. The Journal of Immunology 196:4, pages 1568-1578.
Crossref
HAIJUN LI, DONGBEI LI, JITONG SUN, YINAN LI, WEI YANG & YI LI. (2016) Autoimmune regulator-overexpressing dendritic cells induce T helper 1 and T helper 17 cells by upregulating cytokine expression. Molecular Medicine Reports 13:1, pages 565-571.
Crossref
J. Subburayalu & B. Wilde. (2015) “Programmed-cell-death”-Protein 1 (PD-1/CD279)Programmed cell death protein 1 (PD-1/CD279). Der Nephrologe 11:1, pages 70-72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.